{"schema_version":"1","generated_at":"2026-11-08T21:41:39.499Z","data_as_of":"2026-11-08","url":"https://www.findmykol.com/kol/sanjay-popat","json_url":"https://www.findmykol.com/kol/sanjay-popat/profile.json","record_kind":"full","profile_kind":"research","person":{"slug":"sanjay-popat","name":"Sanjay Popat","title":"Chief Medical Officer, The Royal Marsden NHS Foundation Trust","specialty":"Medicine","therapeutic_area":"Lung","therapeutic_areas":["Lung"],"institution":"The Royal Marsden NHS Foundation Trust","institution_url":"https://www.findmykol.com/institution/the-royal-marsden-nhs-foundation-trust","register":{"country":"GB"}},"identifiers":{"orcid":"0000-0003-2087-4963","openalex":"A5048231332"},"summary":"Sanjay Popat is Chief Medical Officer, The Royal Marsden NHS Foundation Trust at The Royal Marsden NHS Foundation Trust. OpenAlex indexes 838 publications with 31,310 citations (h-index 64); ClinicalTrials.gov lists 13 registered studies with this person as an investigator.","overview":{"text":"Sanjay Popat is Chief Medical Officer, The Royal Marsden NHS Foundation Trust. The public record shows 838 publications with 31,310 citations (h-index 64), centered on Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, Lung Cancer Research Studies. It also documents an investigator role on 13 registered clinical trials.","bullets":["Most recent indexed publication: 2026 · JCO precision oncology","Top research focus: Lung Cancer Treatments and Mutations","13 registered trials on ClinicalTrials.gov"],"generated_at":"2026-11-08"},"focus":{"indications":[{"label":"Lung Cancer (NSCLC/SCLC)","therapeutic_area":"Oncology","trials":8,"topics":0,"strength":25},{"label":"Small Cell Lung Carcinoma","therapeutic_area":"Oncology","trials":7,"topics":0,"strength":21},{"label":"Mesothelioma","therapeutic_area":"Oncology","trials":3,"topics":0,"strength":9},{"label":"Lymphoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":4},{"label":"Colorectal Cancer","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":4},{"label":"Ovarian / Gynecologic Cancer","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":4},{"label":"Breast Cancer","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":4},{"label":"Gastroesophageal Cancer","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":4},{"label":"Hepatobiliary Cancer","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Rectal Neoplasms","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Biliary Tract Neoplasms","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Gastrointestinal Stromal Tumors","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Mesothelioma, Malignant","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Stomach Neoplasms","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Esophageal Neoplasms","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Carcinoma, Squamous Cell","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Adenocarcinoma of Lung","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Multiple Myeloma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Head & Neck Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Tuberculosis","therapeutic_area":"Infectious Disease","trials":0,"topics":0,"strength":1},{"label":"Type 2 Diabetes","therapeutic_area":"Endocrinology/Metabolic","trials":0,"topics":0,"strength":1},{"label":"COPD","therapeutic_area":"Respiratory","trials":0,"topics":0,"strength":1},{"label":"Thyroid Disorders","therapeutic_area":"Endocrinology/Metabolic","trials":0,"topics":0,"strength":1},{"label":"COVID-19","therapeutic_area":"Infectious Disease","trials":0,"topics":0,"strength":1},{"label":"Pancreatic Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Kidney Cancer / RCC","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Sarcoma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Cushing's Syndrome","therapeutic_area":"Endocrinology/Metabolic","trials":0,"topics":0,"strength":1},{"label":"Chronic Kidney Disease","therapeutic_area":"Nephrology","trials":0,"topics":0,"strength":1},{"label":"Neuro-Oncology / Glioma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Acromegaly","therapeutic_area":"Endocrinology/Metabolic","trials":0,"topics":0,"strength":1},{"label":"Idiopathic Pulmonary Fibrosis","therapeutic_area":"Respiratory","trials":0,"topics":0,"strength":1},{"label":"Bladder / Urothelial Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Prostate Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Leukemia (AML/ALL/CML/CLL)","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Melanoma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Myasthenia Gravis","therapeutic_area":"Neurology","trials":0,"topics":0,"strength":1},{"label":"IBS / Functional GI","therapeutic_area":"Gastroenterology","trials":0,"topics":0,"strength":1},{"label":"Sepsis / Serious Bacterial","therapeutic_area":"Infectious Disease","trials":0,"topics":0,"strength":1}],"research_topics":["Lung Cancer Treatments and Mutations","Lung Cancer Diagnosis and Treatment","Lung Cancer Research Studies","Cancer Immunotherapy and Biomarkers","Cancer Genomics and Diagnostics"],"drugs_studied":{"total":6,"shown":3,"withheld":3,"rows":[{"name":"Alectinib","trials":1,"payments":0,"publications":3,"mentions":4},{"name":"Pemetrexed","trials":1,"payments":0,"publications":1,"mentions":2},{"name":"Atezolizumab","trials":1,"payments":0,"publications":0,"mentions":1}]},"works_with":{"total":5,"shown":3,"withheld":2,"rows":[{"name":"European Organisation for Research and Treatment of Cancer - EORTC","trials":4,"payments":0,"mentions":4},{"name":"Royal Marsden NHS Foundation Trust","trials":4,"payments":0,"mentions":4},{"name":"ETOP IBCSG Partners Foundation","trials":3,"payments":0,"mentions":3}]}},"scholarship":{"works_count":838,"cited_by_count":31310,"h_index":64,"i10_index":257,"pubmed_count":39,"latest_activity_year":2026,"source":"works"},"trials":{"count":13,"shown":3,"withheld":10,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT07673861","title":"Clinical Utility of ctDNA in Detecting Resistance Mechanisms and Delivering Precision Medicine to Cancer Patients","phase":"NA","status":"RECRUITING","role":"Investigator","sponsor":"Royal Marsden NHS Foundation Trust","source_url":"https://clinicaltrials.gov/study/NCT07673861"},{"nct":"NCT07008742","title":"Feasibility Study of Tissue and Blood Collection in Oncogene-addicted and Neoadjuvantly Treated Non Small Cell Lung Cancer","status":"RECRUITING","role":"Investigator","sponsor":"Royal Marsden NHS Foundation Trust","source_url":"https://clinicaltrials.gov/study/NCT07008742"},{"nct":"NCT06765109","title":"Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC","phase":"PHASE3","status":"RECRUITING","role":"Investigator","sponsor":"Nuvalent Inc.","source_url":"https://clinicaltrials.gov/study/NCT06765109","trial_url":"https://www.findmykol.com/trial/NCT06765109"}],"source":"trials"},"payments":{"note":"Not attributed. This person has no U.S. clinical registration (NPI) on file, so industry payments cannot be reliably tied to them."},"funding":{"award_count":0,"rows_total":0,"shown":0,"withheld":0,"rows":[],"source":"grants"},"congress":{"count":195,"years":{"first":2004,"last":2026},"societies":["AACR","ASCO","ASTRO","ESMO","ESTRO Congress","IASLC","ISPOR","ISPOR Europe"],"shown":3,"withheld":192,"rows":[{"title":"Abstract 2711: Large-scale integration of single-nuclei and spatial transcriptomics from the ETOP BEAT-meso trial reveals clinically relevant heterogeneity in malignant pleural mesothelioma.","society":"AACR","meeting":"AACR Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1158/1538-7445.am2026-2711","source_url":"https://doi.org/10.1158/1538-7445.am2026-2711","status":"verified"},{"title":"Abstract CT215: RASolve 301: A Phase 3 study of daraxonrasib (RMC-6236) vs. docetaxel in patients with previously treated RAS-mutant NSCLC","society":"AACR","meeting":"AACR Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1158/1538-7445.am2026-ct215","source_url":"https://doi.org/10.1158/1538-7445.am2026-ct215","status":"verified"},{"title":"Abstract CT248: Zidesamtinib in patients with ROS1+ NSCLC previously treated with repotrectinib or taletrectinib","society":"AACR","meeting":"AACR Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1158/1538-7445.am2026-ct248","source_url":"https://doi.org/10.1158/1538-7445.am2026-ct248","status":"verified"}],"source":"congress"},"publications":{"total":39,"shown":5,"withheld":34,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"Genomic Analysis Using Liquid Biopsy: Considerations for Pretest Counseling in UK Practice.","year":2026,"journal":"JCO precision oncology","types":["Journal Article","Review"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42842845/","status":"verified"},{"title":"Reply to: \"Beyond Response Rates: Interpreting Long-Term Benefit in CheckMate 743\" and \"Beyond Statistical Significance: Methodologic Fragility and Censoring Bias in the 5-Year Update of CheckMate 743\".","year":2026,"journal":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42430671/","status":"verified"},{"title":"Ceralasertib plus durvalumab in Ras mutant and Ras wild type advanced non-small cell lung cancer: Two cohorts of the phase II platform National Lung Matrix Trial.","year":2026,"journal":"Clinical cancer research : an official journal of the American Association for Cancer Research","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42714874/","status":"verified"},{"title":"SUNRAY-02: a study of olomorasib combined with immunotherapy in stage II-III KRAS G12C-mutant non-small cell lung cancer after definitive therapy.","year":2026,"journal":"Future oncology (London, England)","types":["Clinical Trial Protocol","Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42823821/","status":"verified"},{"title":"Unilateral Scleral Icterus as a Rare Presentation of Choroidal Metastasis in Transdifferentiated EGFR-Mutant Lung Cancer: A Case Report and Review of the Literature.","year":2026,"journal":"Lung Cancer (Auckland, N.Z.)","types":["Case Reports","Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42683416/","status":"verified"}],"source":"publications"},"presence":{"owned_accounts":{"total":1,"shown":1,"rows":[{"platform":"x","url":"https://x.com/DrSanjayPopat","status":"verified"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"social_posts":{"stored_total":1,"shown":1,"withheld":0,"rows":[{"platform":"x","post_id":"2037943631315706063","url":"https://x.com/drsanjaypopat/status/2037943631315706063","handle":"drsanjaypopat","posted_at_from_id":"2026-03-28T17:23:19.524Z","collected_at":"2026-11-05T21:41:16.826Z","sources":[{"hub":"elcc26","society_slug":null,"meeting_year":null,"relevance":"within_meeting_dates","source_urls":["https://kolpulse.com/kol-pulse-trial-profile-itimes"]}]}],"coverage":"Saved references from selected congress pages, joined through reviewed account identifiers. Not a complete X history or evidence of attendance. Post availability may change."},"recognition":{"education":{"total":1,"shown":1,"rows":[{"value":"BSc, MBBS, FRCP, PhD","source_url":"https://www.onclive.com/authors/sanjay-popat-bsc-mbbs-frcp-phd","status":"provisional","collected_at":"2026-11-08"}]},"roles":{"total":2,"shown":2,"rows":[{"value":"Chair, British Thoracic Oncology Group Steering Committee (2013-present)","source_url":"https://www.esmo.org/Profiles/Sanjay-Popat","status":"provisional","collected_at":"2026-11-08"},{"value":"Chair, NCRI Lung Cancer Clinical Studies Group Advanced Disease Sub-group","source_url":"https://www.icr.ac.uk/our-research/researchers-and-teams/professor-sanjay-popat","status":"provisional","collected_at":"2026-11-08"}]},"secondary_affiliations":{"total":1,"shown":1,"rows":[{"value":"Professor of Thoracic Oncology, Institute of Cancer Research","source_url":"https://www.esmo.org/Profiles/Sanjay-Popat","status":"provisional","collected_at":"2026-11-08"}]},"media":{"total":1,"shown":1,"rows":[{"value":"Episode 79: Dr Sanjay Popat, Dave Bjork (2023), podcast","source_url":"https://puma-potato-bxn6.squarespace.com/podcast/episode-79-dr-sanjay-popat-dave-bjork-2023","status":"provisional","collected_at":"2026-11-08"}]}},"similar":[{"name":"Ignacio Wistuba","slug":"ignacio-wistuba","institution":"Moffitt Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/ignacio-wistuba","json_url":"https://www.findmykol.com/kol/ignacio-wistuba/profile.json"},{"name":"Pasi Janne","slug":"pasi-janne","institution":"Dana-Farber Cancer Institute","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/pasi-janne","json_url":"https://www.findmykol.com/kol/pasi-janne/profile.json"},{"name":"Julie Brahmer","slug":"julie-brahmer","institution":"Johns Hopkins University School of Medicine","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/julie-brahmer","json_url":"https://www.findmykol.com/kol/julie-brahmer/profile.json"},{"name":"Enriqueta Felip","slug":"enriqueta-felip","institution":"Vall d'Hebron Institute of Oncology (VHIO)","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/enriqueta-felip","json_url":"https://www.findmykol.com/kol/enriqueta-felip/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":10,"congress":192,"publications":34}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-11-08"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-11-08"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-11-08"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-11-08"}},"methodology_url":"https://www.findmykol.com/about#methodology"}